Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Clinical trials reveal quality of BacoMindA team of experts from Swinburne University of Technology, Australia reviewed the randomized, controlled clinical trials to evaluate the cognitive effects of B monnieri and published a systematic review in J of Alternative and Complementary Medicine.
By: www.naturalremedy.com The trials were analyzed for methodologic quality using a purpose-designed modified Jadad scale of total 10 points. Here, one point was given when each of the following criteria was satisfied, with higher scores reflecting superior methodologic quality: (I) Was the study randomized? (II) Was randomization detailed and appropriate? The Systematic review included two of the clinical studies on BacoMind viz 1) Morgan and Stevens (2010) titled “Does Bacopa monnieri improve memory performance in older persons? results of randomized, placebo-controlled double-blind trial” and, 2) Barbhiya et al., (2008) titled “Efficacy and tolerability of BacoMind on memory improvement in elderly participants - A double blind placebo controlled study”, have scored highest on the Jadad scale for quality amongst the studies included. BacoMind is a clinically proven (both in elderly and children) standardized phytochemical composition derived from the plant Bacopa monnieri Linn, and is launched after an extensive research work by Natural Remedies, Bangalore. BacoMind has scientific backup of multiple in vitro, animal and clinical studies to substantiate its beneficial effects for cognition. Further, this systematic review adds value by revealing the quality of the studies conducted on BacoMind for cognitive enhancement. Visit bacomind.com for more on BacoMind. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|